Supplementary Table 1 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial Edwin Roger Parra , Jiexin Zhang , Dzifa Yawa Duose , Edgar Gonzalez-Kozlova , Mary W. Redman , Hong Chen , Ganiraju C. Manyam , Gayatri Kumar , Jianhua Zhang , Xingzhi Song , Rossana Lazcano , Mario L. Marques-Piubelli , Caddie Laberiano-Fernandez , Frank Rojas , Baili Zhang , Len Taing , Aashna Jhaveri , Jacob Geisberg , Jennifer Altreuter , Franziska Michor , James Provencher , Joyce Yu , Ethan Cerami , Radim Moravec , Kasthuri Kannan , Rajyalakshmi Luthra , Gheath Alatrash , Hsin-Hui Huang , Hui Xie , Manishkumar Patel , Kai Nie , Jocelyn Harris , Kimberly Argueta , James Lindsay , Roshni Biswas , Stephen Van Nostrand , Seunghee Kim-Schulze , Jhanelle E. Gray , Roy S. Herbst , Ignacio I. Wistuba , Scott Gettinger , Karen Kelly , Lyudmila Bazhenova , Sacha Gnjatic , J. Jack Lee , Jianjun Zhang , Cara Haymaker crossref（2024）
Abstract
Supplementary Table 1. Clinicopathologic from total patients and according to assay.
More Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
